The Medical Imaging and Technology Alliance (MITA) commended the U.S. Senate for including a bipartisan provision in the Opioid Crisis Response Act of 2018 to facilitate the development of ultrasound technologies as an alternative to using opioids for pain management.

Russia and President Donald Trump’s Twitter feed might grab more headlines, but healthcare is still expected to be one of the most important issues of the midterm elections in November. And some candidates are using their own healthcare experiences—including their battles against cancer—as a way to connect with voters and continue the country’s ongoing healthcare debate.

The U.S. Senate passed the Opioid Crisis Response Act on Monday, Sept. 17. The bill will authorize $7.9 billion for health agencies, including the CDC and HHS. It includes a provision that may facilitate the development on ultrasound-based therapies, a move supported by the Medical Imaging & Technology Alliance (MITA).

The American College of Radiology (ACR) and numerous colorectal cancer care advocacy groups issued a statement this week calling for Congress to pass the CT Colonography Screening for Colorectal Cancer Act (HR 1298).

Healthcare costs continue to balloon in the United States, and secret contracts between hospital systems and insurers may be playing a big role in keeping those costs up.

The Senate approved a major bill to tackle the opioid crisis with a nearly unanimous vote.

The International Contrast Ultrasound Society (ICUS) has urged the U.S. FDA to remove boxed warnings from ultrasound contrast agents based on research demonstrating its safety and clinical benefits.

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.